Literature DB >> 29532444

Metabolic Enhancer Piracetam Attenuates the Translocation of Mitochondrion-Specific Proteins of Caspase-Independent Pathway, Poly [ADP-Ribose] Polymerase 1 Up-regulation and Oxidative DNA Fragmentation.

Dinesh Kumar Verma1, Sonam Gupta1, Joyshree Biswas1, Neeraj Joshi2, K Sivarama Raju3, Mu Wahajuddin3, Sarika Singh4.   

Abstract

Piracetam, a nootropic drug, has been clinically used for decades; however, its mechanism of action still remains enigmatic. The present study was undertaken to evaluate the role of mitochondrion-specific factors of caspase-independent pathway like apoptotic-inducing factor (AIF) and endonuclease-G (endo-G) in piracetam-induced neuroprotection. N2A cells treated with lipopolysaccharide (LPS) exhibited significant cytotoxicity, impaired mitochondrial activity, and reactive oxygen species generation which was significantly attenuated with piracetam co-treatment. Cells co-treated with LPS and piracetam exhibited significant uptake of piracetam in comparison to only piracetam-treated cells as estimated by liquid chromatography-mass spectrometry (LC-MSMS). LPS treatment caused significant translocation of AIF and endonuclease-G in neuronal N2A cells which were significantly attenuated with piracetam co-treatment. Significant over-expression of proinflammatory cytokines was also observed after treatment of LPS to cells which was inhibited with piracetam co-treatment demonstrating its anti-inflammatory property. LPS-treated cells exhibited significant oxidative DNA fragmentation and poly [ADP-ribose] polymerase-1 (PARP-1) up-regulation in nucleus, both of which were attenuated with piracetam treatment. Antioxidant melatonin but not z-VAD offered the inhibited LPS-induced DNA fragmentation indicating the involvement of oxidative DNA fragmentation. Further, we did not observe the altered caspase-3 level after LPS treatment initially while at a later time point, significantly augmented level of caspase-3 was observed which was not inhibited with piracetam treatment. In total, our findings indicate the interference of piracetam in mitochondrion-mediated caspase-independent pathway, as well as its anti-inflammatory and antioxidative properties. Graphical Abstract Graphical abstract indicating the novel interference of metabolic enhancer piracetam (P) in neuronal death mechanisms.

Entities:  

Keywords:  Apoptosis-inducing factor (AIF); DNA fragmentation; Endonuclease-G; Lipopolysaccharide; Piracetam; Poly (ADP-ribose) polymerase-1 (PARP-1)

Mesh:

Substances:

Year:  2018        PMID: 29532444     DOI: 10.1007/s12640-018-9878-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  85 in total

Review 1.  Piracetam: novelty in a unique mode of action.

Authors:  W E Müller; G P Eckert; A Eckert
Journal:  Pharmacopsychiatry       Date:  1999-03       Impact factor: 5.788

2.  Loss of mitochondrial membrane potential is associated with increase in mitochondrial volume: physiological role in neurones.

Authors:  Dzhamilja Safiulina; Vladimir Veksler; Alexander Zharkovsky; Allen Kaasik
Journal:  J Cell Physiol       Date:  2006-02       Impact factor: 6.384

Review 3.  Mitochondrial membrane permeabilization in cell death.

Authors:  Guido Kroemer; Lorenzo Galluzzi; Catherine Brenner
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  A study to evaluate the effect of nootropic drug-piracetam on DNA damage in leukocytes and macrophages.

Authors:  Sarika Singh; Poonam Goswami; Supriya Swarnkar; Sheelendra Pratap Singh; Chandishwar Nath; Sharad Sharma
Journal:  Mutat Res       Date:  2011-09-06       Impact factor: 2.433

5.  Phosphatidylserine externalization is a downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis.

Authors:  M Naito; K Nagashima; T Mashima; T Tsuruo
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

Review 6.  PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases.

Authors:  Sara Martire; Luciana Mosca; Maria d'Erme
Journal:  Mech Ageing Dev       Date:  2015-04-13       Impact factor: 5.432

7.  [Phezam efficacy in patients with chronic cerebral ischemic disease].

Authors:  A N Boĭko; A A Kabanov; T A Es'kina; L A Sheliakina; A I Shchukin; T T Batysheva; I Iu Artemova; T V Vdovichenko; S A Volovets; P A Ganzhula
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2005

Review 8.  Endonuclease activation and chromosomal DNA fragmentation during apoptosis in leukemia cells.

Authors:  Akira Yoshida; Yves Pommier; Takanori Ueda
Journal:  Int J Hematol       Date:  2006-07       Impact factor: 2.490

9.  Piracetam ameliorated oxygen and glucose deprivation-induced injury in rat cortical neurons via inhibition of oxidative stress, excitatory amino acids release and P53/Bax.

Authors:  Zhi He; Min Hu; Yun-hong Zha; Zi-cheng Li; Bo Zhao; Ling-ling Yu; Min Yu; Ying Qian
Journal:  Cell Mol Neurobiol       Date:  2014-02-26       Impact factor: 5.046

10.  Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation.

Authors:  Genevieve Bureau; Fanny Longpré; M-G Martinoli
Journal:  J Neurosci Res       Date:  2008-02-01       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.